Company Overview

NeuroMetrix is a commercial stage company that was founded in 1996 as a spinoff from the Harvard-MIT Division of Health Sciences and Technology. The Company has three commercial products. DPNCheck® is a diagnostic device that provides rapid, point-of-care detection of peripheral neuropathies. ADVANCE® is a diagnostic device that provides automated, in-office nerve conduction studies for the evaluation of focal neuropathies. Quell® is a wearable neurostimulation device indicated for treatment of lower extremity chronic pain.

The Company is based in Woburn, MA.

To visit the NeuroMetrix corporate website click here.